Factor IX: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 52: Line 52:
'''Mutations:'''  
'''Mutations:'''  
Phe496 correspond to residue  16: Consensus phenylalanine to alanine leads to a reduced affinity of the internal propeptide for the propeptide binding site.  
Phe496 correspond to residue  16: Consensus phenylalanine to alanine leads to a reduced affinity of the internal propeptide for the propeptide binding site.  


Val502 corresponds to position  10, Consensus val to alanine, leads to an increase in the affinity of the proposed internal propeptide for the propeptide binding site.  
Val502 corresponds to position  10, Consensus val to alanine, leads to an increase in the affinity of the proposed internal propeptide for the propeptide binding site.  


Glutamine 503 corresponds to position  9, Consensus Gln to Arg leads to a reduced affinity of the internal propeptide for the propeptide binding site. Consensus Gln to Asn, leads the consensus residue to have  a modest increase in the apparent affinity.  
Glutamine 503 corresponds to position  9, Consensus Gln to Arg leads to a reduced affinity of the internal propeptide for the propeptide binding site. Consensus Gln to Asn, leads the consensus residue to have  a modest increase in the apparent affinity.  


Pro 504 corresponds to position  8, not a highly conserved position; however, the propeptide may have an  -helical structure (6), and in this case the proline will disrupt the substrate propeptide helix. Changing proline 504 to the consensus sequence residue, glutamine, has a small increase in the affinity of the internal propeptide for its binding site.  
Pro 504 corresponds to position  8, not a highly conserved position; however, the propeptide may have an  -helical structure (6), and in this case the proline will disrupt the substrate propeptide helix. Changing proline 504 to the consensus sequence residue, glutamine, has a small increase in the affinity of the internal propeptide for its binding site.  


These mutations identified that residues 495-513 in the carboxylase act as an internal propeptide binding site (7).  
These mutations identified that residues 495-513 in the carboxylase act as an internal propeptide binding site (7).